Subscribe To
BNTX / The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
BNTX News
By Reuters
October 26, 2023
Pfizer, BioNtech say flu-COVID shot generates immune response
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against the viru more_horizontal
By CNBC Television
October 16, 2023
Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman
Evan Seigerman, BMO Capital Markets analyst, joins 'Closing Bell: Overtime' to discuss Pfizer and BioNTech cutting guidance amid Covid sales falling, more_horizontal
By Forbes
October 16, 2023
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral drug Paxlovid. more_horizontal
By Proactive Investors
October 16, 2023
Pfizer and BioNtech take big write-downs on Covid jab stocks
Covid vaccine developer BioNTech is to take a write-down of up to €900 million on its stocks of jabs following a similar provision by partner Pfize more_horizontal
By Market Watch
October 16, 2023
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
Shares of Lululemon Athletica Inc. LULU, +1.00% rallied more than 5% after index provider S&P Dow Jones Indices said the stock will join the S&P 500 i more_horizontal
By Reuters
October 16, 2023
BioNTech will likely take 900 mln eur write-off on Pfizer-partnered vaccines
Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947 million) in the third quarter after its partner Pf more_horizontal
By GlobeNewsWire
October 16, 2023
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c more_horizontal
By The Motley Fool
September 29, 2023
Why Pfizer and BioNTech Stocks Zoomed Higher Today
While people in this country aren't rushing in masses to get updated COVID booster vaccines, take-up has been encouraging. Many are worried about an a more_horizontal